Key Highlights
● The S&P 500 recorded 14 new 52-week highs and only 5 new lows.
● The NYSE logged 141 new highs against 183 new lows.
● Palantir, Datadog and Moderna were among the large-cap standouts.
● Only 182 S&P 500 members finished above their 50-day averages.
The S&P 500 recorded 14 new 52-week highs and only 5 new 52-week lows on Friday, according to market data. The index itself rose 46.18 points to 7,811.54, finishing about 7 points below its record close of 7,818.93 set on Tuesday, October 6.
The count of new highs and new lows is a simple way of measuring how many stocks are in strong uptrends versus deep downtrends. When an index sits near records, analysts like to see plenty of members making new highs, because it suggests strength is spread around rather than concentrated in a few names.
A sharp contrast with the broader market
The large-cap tally stood out against the rest of the market. On the New York Stock Exchange, there were 141 new highs against 183 new lows. On the Nasdaq, the gap was far wider, with 41 new highs and 209 new lows. The Nasdaq has posted more new lows than new highs for 30 straight sessions.
The difference reflects who is winning in the current environment. Big, established companies with strong balance sheets have weathered high interest rates better than smaller ones. The 10-year Treasury yield is near a 24-year high, the Fed raised rates in September for the first time since 2023, and Fed Governor Christopher Waller said on Thursday that he anticipates additional hikes to bring inflation back to the Fed's goal. Such conditions tend to weigh most heavily on smaller, more indebted firms, which make up a large share of the broader exchanges.
Who was reaching for highs
Several large caps hit notable peaks. Palantir (NASDAQ:PLTR) rose $10.27 to $209.05, a record close according to market data, after Barclays (NYSE:BCS) initiated coverage at Overweight with a $265 target. Datadog (NASDAQ:DDOG) climbed to a new 52-week high in the afternoon after CIBC (NYSE:CM) reiterated its Outperform rating and raised its price target. Moderna (NASDAQ:MRNA) surged $28.00 to $225.00, its highest level since 2021, on a report about an NIH-linked cancer-vaccine initiative.
Elsewhere, Humana (NYSE:HUM) soared $44.75 to $431.87 on strong Medicare Advantage star ratings, and tower owner Crown Castle (NYSE:CCI) jumped $10.75 to $79.64 on SpaceX (NASDAQ:SPCX)'s spectrum purchase.
And who was sinking
The same SpaceX deal pushed telecom carriers sharply lower. T-Mobile US (NASDAQ:TMUS) fell to its lowest level in more than 33 months in early trade, according to market data, and closed around $148.58. AT&T (NYSE:T) and Verizon (NYSE:VZ) tumbled as well. Apple (NASDAQ:AAPL) suppliers came under pressure after a report said Apple had told suppliers to cut iPhone 18 Pro component production for October, and a slide in Skyworks Solutions (NASDAQ:SWKS) was tied to that report.
Reading the signal
A 14-to-5 split is constructive but small in absolute terms for a 500-stock index. Only 182 S&P 500 members finished above their 50-day moving averages, according to market data, a little over a third of the index. Trading volume was light, at 14.37 billion shares against a 20-day average of 17.76 billion. Ross Mayfield of Baird said: "That's why it's a fairly tepid rally."
In short, the leaders are leading, but plenty of the index's members are still catching up.
Earnings Season Could Reshuffle the New-High List
Earnings season could reshuffle the new-high and new-low lists. The big banks report from Tuesday, October 13, and the September consumer price index is due on Wednesday, October 14, followed by producer prices and retail sales on Thursday. Stocks trade on Columbus Day Monday while bonds are closed. The Fed's next meeting is October 27–28.






Please wait processing your request...